US OptionsDetailed Quotes
ALUR241220P5000
- 0.00
- 0.000.00%
15min DelayClose Nov 22 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover562.62%IV-1065.50%PremiumDec 20, 2024Expiry Date4.57Intrinsic Value100Multiplier26DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8187Delta0.4518Gamma0.09Leverage Ratio-0.0029Theta-0.0017Rho-0.08Eff Leverage0.0003Vega
Allurion Technologies Stock Discussion
📊⚡️📊
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon
Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss
Allurion Technologies (NYSE: ALUR) has announced the publication of a meta-analysis demonstrating the safety and effectiveness of the Allurion Program for weight loss. The systematic review, which analyzed 11 studies involving 2,107 patients conducted between 2016 and 2024, reported an average weight reduction of 12.5% and a sign...
Lot to catch up and learn. 🫠
#weemorning #shareyourprofitloss
loading...
Allurion Receives Continued Listing Standards Notice from NYSE
Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity
Allurion Technologies (NYSE: ALUR) has published a study on the safety and effectiveness of the Allurion Program in adolescents with obesity. The study involved 91 adolescents aged 15-17 with an average BMI of 35.6. Key findings include:
- Average weight reduction of 13.1% four months after balloon placement
- No serious adverse events or early device re...
Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program
Allurion Technologies (NYSE: ALUR) has published a study showing impressive weight loss results with its Allurion Program. 486 patients achieved an average weight reduction of 10.5% at four months, improving to 13.7% at one year. The program combines the Allurion Balloon with virtual guidance and support, including monthly assessments using the A...
No comment yet